SeqOnce BioSciences, Inc. is a privately held genomics tools company located in Carlsbad, CA. Focus areas include infectious disease, qPCR, NGS, and development
SeqOnce Biosciences - Expands Their Pathogen Assay Suite with the Addition of RT-qPCR Measles Panel
News provided by
SeqOnce Biosciences, Inc.
Jul 01, 2025, 10:30 ET
CARLSBAD, Calif., July 1, 2025 /PRNewswire/ -- SeqOnce, a company focused on the research, development, and commercialization of qPCR and NGS genomics tools for the Infectious Disease Research & CLIA Testing Market, has launched their new Measles Panel A.
"This expansion of our best-in-class RT-qPCR assays for our customers ensures that we can effectively partner throughout their pathogen analysis, from the earliest development stages to clinical research to screening patient samples, where working with multiplex qPCR kits is needed," says SeqOnce CEO Chris Angermayer. "We are committed to constantly improving and innovating our offerings to keep pace with the evolving field of Infectious Disease Research & CLIA Testing Market. Whatever we can do to help keep our environment and community safe by providing genomic tools for those who need them, we will do."
SeqOnce's Measle Panel A was developed due to the increase in Measle cases in the United States. Measle Panel A is compatible with Bio-Rad, Roche and ABI qPCR systems. The assay has been specially formulated to detect the D8 genotype responsible for the recent outbreak in the United States but will also detect all know circulating viruses.
"Our approach to product development involves talking to our customers about what they need based on trends in the marketplace. Once we see a need we can solve, we get to work using our Bioinformatic tools to design the panels that work with our enzymes, fluorophores and buffers" says SeqOnce Chief Science Officer Joe Dunham. "Using this approach allows us to develop high quality products for our customers that use our other products as well.
SeqOnce's product portfolio includes multiplex qPCR assay for Respiratory Diseases, Women's Health and Antibiotic Resistance.
Please visit our website at https://t.co/GhJtVCg9iI to learn more.
About SeqOnce, Inc.
SeqOnce BioSciences, Inc. is a privately held genomics tools company located in Carlsbad, CA. Focus areas include infectious disease, qPCR, NGS, and development of novel technology platforms that are used for Research Only efforts.
https://t.co/GhJtVCg9iI
For SeqOnce Information Contact:
Chris Angermayer at 1 (626)460-3050
SOURCE SeqOnce Biosciences, Inc.
SeqOnce Biosciences, Inc's Reg CF offering is available from Republic. Please see our company presentation and visit Republic if interested in investing at the following link.
https://t.co/aEod1rjXXA
SeqOnce RhinoSeq simplifies the complex #NGS DNA library construction workflow. See results from human WGS, FFPE and HLA typing in this #ASHG19 poster. #FollowTheRhino#DNAsequencing https://t.co/lrCA682lvT
Visit us on booth 400 today if you missed the opportunity to talk to the scientist behind the fastest DNA library kit on the market. You can also met him tomorrow Oct 18 from 1-2pm by poster 1833 #ASHG19#FollowTheRhino#DNAsequencing
RhinoSeq - the fastest, simplest library prep kit for NGS - only 20 min. Start with as low as 10 ng DNA. Meet us at ASHG 2019 on booth 400 https://t.co/zh7677iXIZ #ASHG19#FollowTheRhino#DNAsequencing
SeqOnce technology is revolutionizing genomic research. Read about the Founders and where the company is going! #NGS#DNAlibrary#DNAsequencing#FollowTheRhino https://t.co/WaSxeEIHWn
RhinoSeq - the fastest, simplest library prep kit for NGS - only 20 min. Start with as low as 10 ng DNA. Meet us at ASM 2019 on booth 5323 https://t.co/zh7677iXIZ #ASMicrobe#FollowTheRhino#DNAsequencing#NGS
NGS applications are pushing the limits of detection and accuracy. Learn about sources of sequencing errors and limits of detection. #FollowTheRhino#DNAsequencing#DNAlibrary#NGS https://t.co/VCN0EjWiKE
Congratulations to @Illumina for being no 1 on the list of Top 10 Sequencing companies. @SeqOnce offers RhinoSeq, the fastest library amplification kit for Illumina sequencers. Cut hours off your library prep time! #NGS#DNAsequencing#DNAlibrary
NGS needs to be streamlined and simplified. Introducing SeqOnce and Done blog. We will highlight novel applications, describe useful parameter involved with #NGS, and comment on emerging and current technologies. Check in regularly to learn more https://t.co/XAgYylBzUt
It was a pleasure to meet you at #ABRF2019. As a reminder, we launched RhinoSeq - the fastest DNA library prep for #NGS. If you missed our poster that explains the product in detail - you can read it here. https://t.co/pEPLgO71WM #DNAsequencing#DNAlibrary
Launching at #ABRF2019 - RhinoSeq - fastest DNA library prep for #NGS. Purified DNA to library in 20 min. Learn more on poster 108 Mon Mar 25. 2.30p-3.30p - or stop by any time by the big Rhino at booth 218. https://t.co/rPSXAzQD2W #DNAsequencing#DNAlibrary
What's next in the #genomics revolution? @RodrigoATCG and @mcgenome define 'The Era of The Social Genome' where insights from your #DNA will be integrated into aspects of your everyday life. Check out the thought piece and let us know what you think! https://t.co/g5sjPCkAc9
Launching at #ABRF2019 - RhinoSeq - fastest DNA library prep for #NGS. Purified DNA to library in 20 min. Stop by the big Rhino at booth 218. https://t.co/rPSXAzQD2W #DNAsequencing#DNAlibrary